Summary, Patients will be able to get immunotherapy in the form of a vaccine called nivolumab in just 15 minutes, as opposed to an hour on an IV drip. England becomes the first country in Europe to offer it, with approximately 1,200 people receiving it each month for 15 different types of cancer, including skin, bladder, and oesophageal cancer. The medicine is a monoclonal antibody that attaches to a protein called PD-1 on a type of immune cell known as a T cell. It works by preventing cancer cells from deactivating T-cells, allowing the immune system to target and eliminate cancer cells.

Our boy won’t talk to humans. He has appointed the girl as his spokescat and will headbutt her till she gets human attention. If she is sleeping elsewhere he gets quite confused how to ask for food. Why can’t they just read my ears then??!